Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'purotoxin 1'

Search results for: 'purotoxin 1'

Items 1-10 of 42

Page
per page
  1. Tenovin-1
    A4203 Tenovin-1
    Target: Sir2-like Family Deacetylases (Sirtuins)|p53|p21
    Summary: SIRT2 inhibitor, activates p53
      insoluble in H2O; insoluble in EtOH; ≥15 mg/mL
  2. Sephin1
    A8708 Sephin1
     1 Citation
    Target: phosphatases
    Summary: Selective PPP1R15A inhibitor
      insoluble in H2O; insoluble in EtOH; ≥7.75 mg/mL
  3. PFI-1 (PF-6405761)
    A4184 PFI-1 (PF-6405761)
     1 Citation
    Target: Bromodomains
    Summary: BET inhibitor
      insoluble in H2O; insoluble in EtOH; ≥128.4 mg/mL
  4. Bromodomain Inhibitor, (+)-JQ1
    A1910 Bromodomain Inhibitor, (+)-JQ1
     38 Citation
    Target: Bromodomains
    Summary: BET bromodomain inhibitor
      ≥22.85 mg/mL
  5. BAY 87-2243
    B1115 BAY 87-2243
    Target: Hypoxia Inducible Factors (HIFs)
    Summary: HIF-1 inhibitor,potent and selective
  6. PJ34
    A3729 PJ34
    Target: PARP
    Summary: PARP-l inhibitor
      ≥50.9 mg/mL
  7. ENMD-2076
    A4130 ENMD-2076
    Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms
    Summary: Selective Aurora A/Flt3 inhibitor
      insoluble in H2O; ≥18.75 mg/mL
  8. Cercosporamide
    A4511 Cercosporamide
    Target: JAK|MNK
    Summary: Mnk2 and JAK3 inhibitor
      soluble in DMSO
  9. DMOG
    A4506 DMOG
    Target: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)
    Summary: Competitive HIF-PH inhibitor, cell-permeable
  10. Inauhzin
    B3272 Inauhzin
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 inhibitor
      ≥23.5 mg/mL

Items 1-10 of 42

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 2item
  2. Aurora Kinase 3item
  3. HDAC 11item
  4. Histone Acetyltransferases 1 item
  5. Histone Demethylases 1 item
  6. Histone Methyltransferase 2item
  7. HIF 3item
  8. JAK 7item
  9. PARP 6item
  10. Pim 1 item
  11. Protein Ser/Thr Phosphatases 2item
  12. Sirtuin 3item
Specificity
  1. Selective 28item
Reversibility
  1. Reversible 1 item
  2. Irreversible 1 item
Target
  1. Histone Deacetylases (HDACs) 10item
  2. Aurora Kinases 3item
  3. MDM2 1 item
  4. Bromodomains 2item
  5. FLT3 2item
  6. RET 1 item
  7. DOT1L 1 item
  8. Pim 1 item
  9. Sir2-like Family Deacetylases (Sirtuins) 3item
  10. PP1 1 item
  11. PP2A 1 item
  12. Src 1 item
  13. STAT 1 item
  14. Hypoxia Inducible Factors (HIFs) 1 item
  15. JAK 7item
  16. p300 1 item
  17. TNKS 1 item
  18. Topoisomerases 1 item
  19. DNA Methyltransferases 1 item
  20. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  21. PARP 5item
  22. phosphatases 1 item
  23. Histone Demethylases 1 item
  24. MNK 1 item
  25. Protein Arginine Methyltransferases 1 item
  26. PP4 1 item
  27. c-RET 1 item
  28. VEGFR3/FLT4 1 item
  29. NTRK1/TRKA 1 item
  30. CSF-1R/c-Fms 1 item
  31. p53 2item
  32. Trx 1 item
  33. p21 1 item
  34. 5-HT 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Breast Cancer 4item
  3. Cancer 26item
  4. Cervical Cancer 1 item
  5. Colon Cancer 3item
  6. Colon Carcinoma 1 item
  7. Colorectal Cancer 1 item
  8. Epilepsy 1 item
  9. Glioma 1 item
  10. Hepatic Cancer 1 item
  11. Hepatocellular Carcinoma 1 item
  12. Inflammatory Diseases 1 item
  13. Leukemia 2item
  14. Lung Cancer 1 item
  15. Lymphoma 1 item
  16. Melanoma 1 item
  17. Mixed Lineage Leukemia 1 item
  18. Multiple Myeloma 2item
  19. Myelofibrosis 1 item
  20. Non-small Cell Lung Cancer 2item
  21. Ovarian Cancer 3item
  22. Pancreatic Cancer 2item
  23. Prostate Cancer 4item
  24. Renal Cell Carcinoma 1 item
  25. Rheumatoid Arthritis 1 item